Naproxen and Zejula drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naproxen (naproxen) and Zejula (niraparib tosylate). Common drug interactions include nausea among females.

The phase IV clinical study analyzes what interactions people have when they take Naproxen and Zejula. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,034 Naproxen users. Check the latest studies of Naproxen.

What is Zejula?

Zejula has active ingredients of niraparib tosylate. eHealthMe is studying from 22,014 Zejula users. Check the latest studies of Zejula.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

21 people who take Naproxen and Zejula together, and have interactions are studied.

What are the common drug interactions of Naproxen and Zejula, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Fatigue (feeling of tiredness)
Pruritus (severe itching of the skin)
Urinary tract infection
Haematocrit decreased
Osteopenia (a condition where bone mineral density is lower than normal)
Rash
Thrombocytopenia (decrease of platelets in blood)
Urticaria (rash of round, red welts on the skin that itch intensely)
Photosensitivity reaction

male:

n/a

What are the common drug interactions of Naproxen and Zejula, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Blood pressure increased
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Dizziness
Dry mouth
Dysphonia (speech disorder attributable to a disorder of phonation)
Epistaxis (bleed from the nose)
Eye disorder
Hair colour changes
Hypoacusis (loss of hearing)

60+:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Haematocrit decreased
Osteopenia (a condition where bone mineral density is lower than normal)
Pruritus (severe itching of the skin)
Rash
Recurrent cancer (repeated cancer)
Surgery
Thrombocytopenia (decrease of platelets in blood)
Urinary tract infection

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 17 people, 80.95%
Nausea And Vomiting: 5 people, 23.81%
Nausea (feeling of having an urge to vomit): 5 people, 23.81%
High Blood Pressure: 4 people, 19.05%
Ovarian Epithelial Cancer (cancer that begins in the cells on the surface of the ovary): 2 people, 9.52%
Neuropathy Peripheral (surface nerve damage): 2 people, 9.52%
Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 2 people, 9.52%
Fallopian Tube Cancer (cancer of fallopian tube): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Naproxen and Zejula?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously